지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2016.1
- 수록면
- 103 - 108 (6page)
이용수
초록· 키워드
오류제보하기
Purpose: CC-chemokine ligand 11 (CCL11; eotaxin-1), an eosinophil chemoat-tractant chemokine, has been proposed as a serum marker for prostate cancer (PCa) by two research groups. We investigated the usefulness of CCL11 in diagnosing prostatic diseases, such as benign prostatic hyperplasia (BPH) and PCa.Materials and Methods: CCL11 was measured in the sera of 139 men with BPH, 44 men with PCa, and 45 control men attending an outpatient health-screening clinic. A commercial enzyme-linked immunosorbent assay kit was used to measure CCL11.Results: CCL11 concentrations were significantly higher in men with BPH and PCa than in normal men (72.9±3.15 and 80.0±4.91 pg/ml vs. 57.6±8.24). In addition, a receiver operating characteristic (ROC) analysis of serum CCL11 levels showed that the areas under the ROC curves were 0.661 (p=0.001) and 0.654 (p=0.012) for BPH and PCa, respectively, compared with normal men.Conclusions: CCL11 may be helpful in diagnosing prostatic diseases, such as BPH and PCa.
목차
등록된 정보가 없습니다.
참고문헌 (33)
참고문헌 신청
Matthews AN / 1998 / Eotaxin is required for the baseline level of tissue eosinophils / Proc Natl Acad Sci U S A 95:6273~6278
Solari R / 2015 / Chemokine receptors as therapeutic targets: why aren't there more drugs? / Eur J Pharmacol 746:363~367
Agarwal M / 2013 / CCL11(eotaxin-1) : a new diagnostic serum marker for prostate cancer / Prostate 73:573~581
Heidegger I / 2015 / Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence? / Prostate 75:1904~1909
Daniella Bianchi-Frias / 2010 / The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment / PLoS ONE 5(9):e12501
Solari R / 2015 / Chemokine receptors as therapeutic targets: why aren't there more drugs? / Eur J Pharmacol 746:363~367
Agarwal M / 2013 / CCL11(eotaxin-1) : a new diagnostic serum marker for prostate cancer / Prostate 73:573~581
Heidegger I / 2015 / Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence? / Prostate 75:1904~1909
Daniella Bianchi-Frias / 2010 / The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment / PLoS ONE 5(9):e12501
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
Cancer Research and Treatment
2015 .01
-
Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24
Journal of Pathology and Translational Medicine
2016 .01
-
Expression of Chemokine CCL28 in Ulcerative Colitis Patients
Gut and Liver
2021 .01
-
Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis
Yonsei Medical Journal
2015 .01
-
Effect of CCL11 on In Vitro Myogenesis and Its Clinical Relevance for Sarcopenia in Older Adults
Endocrinology and Metabolism
2021 .01
-
Mechanism of Macrophage-Derived Chemokine/CCL22 Production by HaCaT Keratinocytes
Annals of Dermatology
2015 .01
-
Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis
Parasites, Hosts and Diseases
2016 .04
-
Enriching CCL3 in the Tumor Microenvironment Facilitates T cell Responses and Improves the Efficacy of Anti-PD-1 Therapy
Immune Network
2021 .06
-
Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area
Investigative and Clinical Urology
2015 .01
-
SRD5A2 Gene Polymorphisms and the Risk of Benign Prostatic Hyperplasia but not Prostate Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
전립선비대증 변증도구 개발 기초 연구
대한한방내과학회지
2017 .06
-
Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling
Journal of Breast Cancer
2020 .01
-
Frequency and Type Distribution of Human Papilloma Virus in Patients with Prostate Cancer, Kerman, Southeast of Iran
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Korean clinical practice guideline for benign prostatic hyperplasia
Investigative and Clinical Urology
2016 .01
-
전립선비대증
대한의사협회지
2015 .01
-
Quantification of the Bioactive Components of the Rhizomes of Curcuma wenyujin and Assessment of Its Anti-inflammatory Effect in Benign Prostatic Hyperplasia-1 Cells
Natural Product Sciences
2019 .09
-
Protective effect of Panicum dichotomiflorum in a rat model of testosterone-induced benign prostatic hyperplasia
한국실험동물학회 학술발표대회 논문집
2021 .07
-
Prediction of clinically significant prostate cancer using polygenic risk models in Asians
Investigative and Clinical Urology
2022 .01
-
Benign Prostatic Hyperplasia and the Risk of Falls in Older Men: Insights From a Population-Based Study on Geriatric Morbid Conditions
International Neurourology Journal
2024 .03
-
Differential Chemokine Signature between Human Preadipocytes and Adipocytes
Immune Network
2016 .06
이 논문의 저자 정보
최근 본 자료
댓글(0)
0